Cargando…

PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS

Detalles Bibliográficos
Autores principales: Maria Edoardo Maraglino, Alessio, Amato, Viviana, Gigli, Federica, Sammassimo, Simona, Pastano, Rocco, Tarella, Corrado, Todisco, Elisabetta, Derenzini, Enrico, Giglio, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428832/
http://dx.doi.org/10.1097/01.HS9.0000976564.15756.fd
_version_ 1785090564565237760
author Maria Edoardo Maraglino, Alessio
Amato, Viviana
Gigli, Federica
Sammassimo, Simona
Pastano, Rocco
Tarella, Corrado
Todisco, Elisabetta
Derenzini, Enrico
Giglio, Fabio
author_facet Maria Edoardo Maraglino, Alessio
Amato, Viviana
Gigli, Federica
Sammassimo, Simona
Pastano, Rocco
Tarella, Corrado
Todisco, Elisabetta
Derenzini, Enrico
Giglio, Fabio
author_sort Maria Edoardo Maraglino, Alessio
collection PubMed
description
format Online
Article
Text
id pubmed-10428832
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288322023-08-17 PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS Maria Edoardo Maraglino, Alessio Amato, Viviana Gigli, Federica Sammassimo, Simona Pastano, Rocco Tarella, Corrado Todisco, Elisabetta Derenzini, Enrico Giglio, Fabio Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428832/ http://dx.doi.org/10.1097/01.HS9.0000976564.15756.fd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Maria Edoardo Maraglino, Alessio
Amato, Viviana
Gigli, Federica
Sammassimo, Simona
Pastano, Rocco
Tarella, Corrado
Todisco, Elisabetta
Derenzini, Enrico
Giglio, Fabio
PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS
title PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS
title_full PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS
title_fullStr PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS
title_full_unstemmed PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS
title_short PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS
title_sort pb2465: allogeneic hsct outcomes in six patients with therapy related myeloid neoplasms with a history of ovarian cancer treated with chemoterapy and parp inhibitors
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428832/
http://dx.doi.org/10.1097/01.HS9.0000976564.15756.fd
work_keys_str_mv AT mariaedoardomaraglinoalessio pb2465allogeneichsctoutcomesinsixpatientswiththerapyrelatedmyeloidneoplasmswithahistoryofovariancancertreatedwithchemoterapyandparpinhibitors
AT amatoviviana pb2465allogeneichsctoutcomesinsixpatientswiththerapyrelatedmyeloidneoplasmswithahistoryofovariancancertreatedwithchemoterapyandparpinhibitors
AT giglifederica pb2465allogeneichsctoutcomesinsixpatientswiththerapyrelatedmyeloidneoplasmswithahistoryofovariancancertreatedwithchemoterapyandparpinhibitors
AT sammassimosimona pb2465allogeneichsctoutcomesinsixpatientswiththerapyrelatedmyeloidneoplasmswithahistoryofovariancancertreatedwithchemoterapyandparpinhibitors
AT pastanorocco pb2465allogeneichsctoutcomesinsixpatientswiththerapyrelatedmyeloidneoplasmswithahistoryofovariancancertreatedwithchemoterapyandparpinhibitors
AT tarellacorrado pb2465allogeneichsctoutcomesinsixpatientswiththerapyrelatedmyeloidneoplasmswithahistoryofovariancancertreatedwithchemoterapyandparpinhibitors
AT todiscoelisabetta pb2465allogeneichsctoutcomesinsixpatientswiththerapyrelatedmyeloidneoplasmswithahistoryofovariancancertreatedwithchemoterapyandparpinhibitors
AT derenzinienrico pb2465allogeneichsctoutcomesinsixpatientswiththerapyrelatedmyeloidneoplasmswithahistoryofovariancancertreatedwithchemoterapyandparpinhibitors
AT gigliofabio pb2465allogeneichsctoutcomesinsixpatientswiththerapyrelatedmyeloidneoplasmswithahistoryofovariancancertreatedwithchemoterapyandparpinhibitors